C. Briet and C. R. Piffaretti, Epidemiology of type 1 diabetes and its complications, Rev Prat, vol.68, issue.6, pp.607-610, 2018.

I. B. Hirsch, Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does! Diabetes Care, vol.38, pp.1610-1614, 2015.

B. Guerci, Asymptomatic glycemic instability: how to measure it and which clinical applications? Diabetes Metab, vol.29, pp.179-88, 2003.

G. Su, S. Mi, H. Tao, Z. Li, H. Yang et al., Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care, vol.36, pp.1026-1058, 2013.

P. Choudhary, M. R. Rickels, and P. A. Senior, Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia, Diabetes Care, vol.38, pp.1016-1045, 2015.

L. Heinemann, G. Freckmann, and D. Ehrmann, Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial, Lancet, vol.391, pp.1367-77, 2018.

E. Bosi, P. Choudhary, D. Valk, and H. , the SMILE Study Group. Efficacy and safety of suspendbefore-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial, Lancet Diabetes Endocrinology, vol.7, pp.462-472, 2019.

S. Lablanche, M. C. Vantyghem, and L. Kessler, Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycemia or poorly controlled glycemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial, Lancet Diabetes Endocrinol, vol.6, pp.527-537, 2018.

R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. Neil, 10-year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med, vol.359, issue.15, pp.1577-89, 2008.

W. Group-for-the, D. Group, T. J. Orchard, D. M. Nathan, and D. Brillon, Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality, JAMA, vol.313, issue.1, pp.45-53, 2015.

N. C. Foster, R. W. Beck, K. M. Miller, and S. K. Garg, State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016, Diabetes Technol Ther, vol.21, issue.2, pp.66-72, 2018.

T. Danne, R. Nimri, T. Battelino, and M. Phillip, Consensus on Use of Continuous Glucose Monitoring Diabetes Care, vol.40, pp.1631-1640, 2017.

E. Bosi, P. Choudhary, D. Valk, and H. , the SMILE Study Group. Efficacy and safety of suspendbefore-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial, Lancet Diabetes Endocrinology, vol.7, pp.462-472, 2019.

D. M. Maahs and B. A. Buckingham,

J. W. Lum, Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report. Diabetes Care, vol.39, pp.1175-1184, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01865047

R. A. Lal, M. Basina, D. M. Maahs, K. Hood, B. Buckingham et al., One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System, Diabetes Care, vol.42, pp.2190-2196, 2019.

S. A. Brown, B. P. Kovatchev, and D. Raghinaru, Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes, Trial Research Group, vol.381, pp.1707-1717, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02555438

T. M. Peters and A. Haidar, Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems, Diabet Med, vol.35, issue.4, pp.450-459, 2018.

P. Benhamou, S. Franc, Y. Reznik, and G. Charpentier, On behalf of the DIABELOOP WP7 Trial Investigators. Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial, Lancet Digital Health, vol.1, pp.17-25, 2019.

S. M. Anderson, B. A. Buckingham, and M. D. Breton, Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia, Diabetes Technol Ther, vol.21, pp.356-363, 2019.

A. Abitbol, R. Rabasa-lhoret, and V. Messier, Overnight Glucose Control with Dual-and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial, Diabetes Technol Ther, vol.20, pp.189-196, 2018.

T. Petterson, P. Lee, S. Hollis, B. Young, P. Newton et al., Well-being and treatment satisfaction in older people with diabetes, Diabetes Care, vol.21, pp.930-935, 1998.

M. A. Testa and D. C. Simonson, Assessment of quality of life outcomes, N Engl J Med, vol.334, pp.835-875, 1996.

M. Debaty, P. Baudrant, S. Benhamou, and . Halimi, Évaluation de la qualité de vie en éducation thérapeutique du patient diabétique : intérêts et limites des échelles de mesure standardisées, Médecine des maladies Métaboliques mai, pp.291-293, 2008.

M. F. Pollack, F. W. Purayidathil, S. C. Bolge, and S. A. Williams, Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life, Diabetes Res. Clin. Pract, vol.87, issue.2, pp.204-214, 2010.

C. Bradley, The Diabetes Treatment Satisfaction Questionnaire: DTSQ. Handbook of Psychology and Diabetes: a guide to psychological measurement in diabetes research and practice, pp.111-132, 1994.

M. Peyrot, Y. Xu, and R. R. Rubin, Development and validation of the Diabetes Medication System Rating Questionnaire-Short Form, Diabet Med, vol.31, issue.10, pp.1237-1281, 2014.

M. J. Sampson, H. Singh, K. K. Dhatariya, C. Jones, E. Walden et al., Psychometric validation and use of a novel diabetes in-patient treatment satisfaction questionnaire, Diabet. Med, vol.26, issue.7, pp.729-764, 2009.

A. Liberman and K. Barnard, Diabetes Technology and the Human Factor, Diabetes Technol Ther, vol.20, issue.S1, p.12838, 2018.

, Eric Bergman Introduction to, Human Factors J Diabetes Sci Technol, vol.6, issue.2, pp.229-230, 2012.

M. Hassenzahl, N. Tractinsky, and . User, Behaviour & Information Technology, pp.91-97, 2006.

J. Brooke, «SUS: a "quick and dirty" usability scale» Usability Evaluation In Industry, pp.189-194, 1996.

R. James, Lewis Senior HF Engineer. Can I Leave This One Out? The Effect of Dropping an Item From the, SUS Journal of Usability studies, vol.13, issue.1, 2017.

M. Hassenzahl, M. Burmester, F. Koller, and . Attrakdiff, Ein Fragebogen zur Messung wahrgenommener hedonischer und pragmatischer Qualität, » Mensch & Computer, pp.187-196, 2003.

P. M. Desmet, P. Hekkert, and J. J. Jacobs, When a car makes you smile : development and application of an instrument to measure product emotions, Advances in Consumer Research, vol.27, pp.111-117, 2000.

K. R. Scherer, What are emotions? And how can they be measured, Soc. Sci. Inf, vol.44, issue.4, pp.695-72, 2005.

G. Gronier, Measuring the first impression : testing the validity of the 5 secondtest, Journal of Usability Studies, vol.12, issue.1, pp.8-25, 2016.

S. Vohra, L. Shamseer, and M. Sampson, CONSORT extension for reporting N-of-1 trials (CENT), p.2015

, BMJ, vol.350, p.1738, 2015.

A. Troncone and R. Bonfanti, Daniela Bruttomesso Evaluating the Experience of Children With Type 1 Diabetes and Their Parents Taking Part in an Artificial Pancreas Clinical Trial Over Multiple Days in a, Diabetes Camp Setting Diabetes Care, vol.39, pp.2158-2164, 2016.

K. D. Barnard, T. Wysocki, H. Thabit, M. L. Evans, S. Amiel et al., Psychosocial aspects of closed---and open---loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting, Diabetic Medicine, vol.32, issue.5, pp.601-609, 2015.

B. Kovatchev, P. Cheng, S. M. Anderson, J. E. Pinsker, F. Boscari et al., Loop Control: A Multicenter, vol.6, pp.18-24, 2017.

C. Ziegler, A. Liberman, R. Nimri, I. Muller, S. Klemen?i? et al., Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD---Logic Artificial Pancreas at Home (DREAM4), J Diabetes Res, vol.2015, p.590308, 2015.

J. Kropff, J. Dejong, S. Del-favero, J. Place, M. Messori et al., Psychological outcomes of evening and night closed---loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2---month randomized crossover trial, Diabet Med, vol.34, issue.2, pp.262-71, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01809238

K. D. Barnard, T. Wysocki, V. Ully, J. K. Mader, T. R. Pieber et al., Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy, Journal of Diabetes Science and Technology, vol.11, issue.6, pp.1080-1088, 2017.

S. Lablanche, S. David-tchouda, and J. Margier, Randomised, prospective, medico economic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol, BMJ, vol.7, p.13434, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01781629

, Gil GV The spectrum of brittle diabetes, J R Soc Med, vol.85, issue.5, pp.259-61, 1992.

G. V. Gil, Prevalence and characteristics of brittle diabetes in Britain QJM, vol.89, pp.839-882, 1996.

. Félix, exprimer toute ma gratitude en quelques lignes : merci d'être là et de me supporter au quotidien, merci pour toutes ces belles valeurs et ces leçons de vie que tu m'apportes. Merci pour ton oreille attentive et tes conseils, qui m'aident à devenir

, Merci enfin pour tous ces fous rires et ces situations « inattendues » partagées. On a vécu beaucoup de magnifiques moments ensemble et ce n'est pas fini